• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对肌肉活检组织进行荧光原位杂交(FISH)对2型强直性肌营养不良症(DM2)中(CCTG)n突变进行生物分子鉴定。

Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.

作者信息

Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G

机构信息

Dipartimento di Fisiologia e Biochimica Generali, Università di Milano, Italy.

出版信息

Eur J Histochem. 2004 Oct-Dec;48(4):437-42. doi: 10.4081/918.

DOI:10.4081/918
PMID:15718211
Abstract

Myotonic dystrophy type 2 (DM2) is a dominantly inherited disorder with multisystemic clinical features, caused by a CCTG repeat expansion in intron 1 of the zinc finger protein 9 (ZNF9) gene. The mutant transcripts are retained in the nucleus forming multiple discrete foci also called ribonuclear inclusions. The size and the somatic instability of DM2 expansion complicate the molecular diagnosis of DM2. In our study fluorescence-labeled CAGG-repeat oligonucleotides were hybridized to muscle biopsies to investigate if fluorescence in situ hybridization (FISH), a relatively quick and simple procedure, could be used as a method to diagnose DM2. When FISH was performed with (CAGG)5 probe, nuclear foci of mutant RNA were present in all genetically confirmed DM2 patients (n=17) and absent in all patients with myotonic dystrophy type 1 (DM1; n=5) or with other muscular disease (n=17) used as controls. In contrast, foci were observed both in DM1 and DM2 myonuclei when muscle tissue were hybridized with (CAG)6CA probe indicating that this probe is not specific for DM2 identification. The consistent detection of ribonuclear inclusions in DM2 muscles and their absence in DM1, in agreement with the clinical diagnosis and with leukocyte (CCTG)n expansion, suggests that fluorescence in situ hybridization using (CAGG)5 probes, may be a specific method to distinguish between DM1 and DM2. Moreover, the procedure is simple, and readily applicable in any pathology laboratory.

摘要

2型强直性肌营养不良症(DM2)是一种具有多系统临床特征的常染色体显性遗传病,由锌指蛋白9(ZNF9)基因第1内含子中的CCTG重复序列扩增引起。突变转录本保留在细胞核中,形成多个离散的病灶,也称为核糖核蛋白包涵体。DM2扩增的大小和体细胞不稳定性使DM2的分子诊断变得复杂。在我们的研究中,荧光标记的CAGG重复寡核苷酸与肌肉活检组织杂交,以研究相对快速简单的荧光原位杂交(FISH)方法是否可用于诊断DM2。当用(CAGG)5探针进行FISH时,所有基因确诊的DM2患者(n = 17)均出现突变RNA的核病灶,而所有1型强直性肌营养不良症(DM1;n = 5)患者或用作对照的其他肌肉疾病患者(n = 17)均未出现。相反,当肌肉组织与(CAG)6CA探针杂交时,在DM1和DM2肌细胞核中均观察到病灶,这表明该探针并非DM2特异性识别探针。DM2肌肉中核糖核蛋白包涵体的一致检测以及DM1中未检测到,与临床诊断和白细胞(CCTG)n扩增一致,表明使用(CAGG)5探针的荧光原位杂交可能是区分DM1和DM2的特异性方法。此外,该方法简单,可在任何病理实验室轻松应用。

相似文献

1
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.通过对肌肉活检组织进行荧光原位杂交(FISH)对2型强直性肌营养不良症(DM2)中(CCTG)n突变进行生物分子鉴定。
Eur J Histochem. 2004 Oct-Dec;48(4):437-42. doi: 10.4081/918.
2
Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.在1型和2型强直性肌营养不良中,肌盲蛋白定位于异常RNA的核灶。
Hum Mol Genet. 2001 Sep 15;10(19):2165-70. doi: 10.1093/hmg/10.19.2165.
3
Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies.核糖核蛋白包涵体作为2型强直性肌营养不良的生物标志物,即使在冷冻不当或解冻的骨骼肌活检样本中也是如此。
Eur J Histochem. 2009 Apr-Jun;53(2):e13. doi: 10.4081/ejh.2009.e13.
4
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.肌肉盲样蛋白1核隔离是1型和2型强直性肌营养不良症的分子病理学标志物。
Eur J Histochem. 2006 Jul-Sep;50(3):177-82.
5
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion.在一个与短CCTG扩增相关的2型强直性肌营养不良家族中,核糖核蛋白包涵体与肌肉blind样蛋白的共定位。
J Neurol Sci. 2008 Dec 15;275(1-2):159-63. doi: 10.1016/j.jns.2008.08.007. Epub 2008 Sep 18.
6
Myotonic dystrophy type 2 and related myotonic disorders.2型强直性肌营养不良及相关强直性疾病
J Neurol. 2004 Oct;251(10):1173-82. doi: 10.1007/s00415-004-0590-1.
7
Myotonic dystrophy: emerging mechanisms for DM1 and DM2.强直性肌营养不良:DM1和DM2的新机制
Biochim Biophys Acta. 2007 Feb;1772(2):195-204. doi: 10.1016/j.bbadis.2006.05.013. Epub 2006 Jun 20.
8
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.不同欧洲血统的近端强直性肌病/近端强直性肌营养不良患者2型强直性肌营养不良(CCTG)n重复突变的确认:单一共享单倍型表明存在祖先奠基者效应。
Am J Hum Genet. 2003 Oct;73(4):835-48. doi: 10.1086/378566. Epub 2003 Sep 10.
9
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.核糖核蛋白包涵体和MBNL1核隔离不影响成肌细胞分化,但会改变2型强直性肌营养不良中的基因剪接。
Neuromuscul Disord. 2009 May;19(5):335-43. doi: 10.1016/j.nmd.2009.03.002. Epub 2009 Apr 3.
10
Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.扩展的 [CCTG]n 重复与肌强直性营养不良 2 型(DM2)患者的 CNBP 基因座异常甲基化无关。
Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):917-924. doi: 10.1016/j.bbadis.2017.12.037. Epub 2017 Dec 29.

引用本文的文献

1
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1.环状 ARHGAP10 作为 1 型强直性肌营养不良的候选生物标志物和治疗靶点。
Mol Ther Nucleic Acids. 2025 Jul 30;36(3):102646. doi: 10.1016/j.omtn.2025.102646. eCollection 2025 Sep 9.
2
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1.肌肉特异性基因编辑改善了1型强直性肌营养不良小鼠模型中的分子和表型缺陷。
Clin Transl Med. 2025 Feb;15(2):e70227. doi: 10.1002/ctm2.70227.
3
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the gene.
通过时间控制和肌肉特异性的CRISPR/Cas9介导的该基因中CTG重复序列扩增的缺失。
Mol Ther Nucleic Acids. 2021 Nov 29;27:184-199. doi: 10.1016/j.omtn.2021.11.024. eCollection 2022 Mar 8.
4
Myotonic dystrophy type 2: the 2020 update.肌强直性营养不良 2 型:2020 更新版。
Acta Myol. 2020 Dec 1;39(4):222-234. doi: 10.36185/2532-1900-026. eCollection 2020 Dec.
5
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1.针对强直性肌营养不良1型(DM1)特征性毒性CUG RNA转录本的新型小分子碱基对识别器的设计
Comput Struct Biotechnol J. 2020 Dec 6;19:51-61. doi: 10.1016/j.csbj.2020.11.053. eCollection 2021.
6
Missplicing in Skeletal Muscle as a Cardiac Biomarker in Myotonic Dystrophy Type 1 but Not in Myotonic Dystrophy Type 2.1型强直性肌营养不良而非2型强直性肌营养不良中,骨骼肌的剪接异常作为心脏生物标志物
Front Neurol. 2019 Sep 27;10:992. doi: 10.3389/fneur.2019.00992. eCollection 2019.
7
Aberrant insulin receptor expression is associated with insulin resistance and skeletal muscle atrophy in myotonic dystrophies.肌强直性营养不良症中胰岛素受体表达异常与胰岛素抵抗和骨骼肌萎缩有关。
PLoS One. 2019 Mar 22;14(3):e0214254. doi: 10.1371/journal.pone.0214254. eCollection 2019.
8
SCN4A as modifier gene in patients with myotonic dystrophy type 2.SCN4A 作为 2 型肌强直性营养不良患者的修饰基因。
Sci Rep. 2018 Jul 23;8(1):11058. doi: 10.1038/s41598-018-29302-z.
9
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2.在 1 型肌强直性营养不良患者中对 RNA 诱导沉默复合物进行高通量分析,确定了 miR-29c 及其靶标 ASB2 的失调。
Cell Death Dis. 2018 Jun 28;9(7):729. doi: 10.1038/s41419-018-0769-5.
10
CRISPR/Cas9-Mediated Deletion of CTG Expansions Recovers Normal Phenotype in Myogenic Cells Derived from Myotonic Dystrophy 1 Patients.CRISPR/Cas9介导的CTG重复序列缺失可恢复强直性肌营养不良1型患者来源的成肌细胞的正常表型。
Mol Ther Nucleic Acids. 2017 Dec 15;9:337-348. doi: 10.1016/j.omtn.2017.10.006. Epub 2017 Oct 14.